A Glimpse into the Future: In 2020, Which Patients will Undergo TAVI or SAVR?

Abstract

Transcatheter aortic valve implantation (TAVI) has evolved into a safe and effective procedure to treat symptomatic patients with severe aortic stenosis (AS), with predictable and reproducible results. Rates of important complications such as vascular complications, strokes and paravalvular leaks are lower than ever, because of improved patient selection, systematic use of multidector computer tomography, increasing operator experience and device iteration. Accumulating data suggest that transfemoral TAVI with newer generation transcatheter heart valves and delivery systems is superior to conventional surgical aortic valve replacement among intermediate-and high-risk patients with severe symptomatic AS with regard to all-cause mortality and stroke. One can anticipate that by 2020, the majority of patients with severe symptomatic AS will undergo TAVI as first line therapy, regardless of surgical risk. KeywordsAortic stenosis, aortic valve replacement, transcatheter aortic valve implantation Disclosure: PW has received institutional grants from Medtronic, and proctoring and lecture fees from Medtronic, Edwards Lifesciences and Boston Scientific. CJO'S has no conflicts of interest to declare.

Pakistan Following Foot Prints of Developed World in Structural Interventions: Experience of Transcatheter Aortic Valve Implantation Reported First Time

“…Operator experience and developing institutional protocols may also be considered as a reason for lower success rate during our learning phase. It is seen that with newer generation valve, there was no increase in mortality although the PVL and permanent pacemaker implant was still increased [ 22 ].…”

“…With advancement in the use of CT, increasing operator experience, improved patient selection, advanced device delivery system and newer-generation valves, TAVI is advancing. O’Sullivan anticipated that by 2020, majority of patients worldwide will undergo TAVI as first-line of management [ 22 ]. So with all the above features of the initial experience of TAVI program in NICVD, it is mandatory to have this new and growing mode of treatment in the country.…”

How yarn orientation limits fibrotic tissue ingrowth in a woven polyester heart valve scaffold: a case report

“…Transcatheter Aortic Valve Implantation (TAVI), minimally invasive valve replacement has been performed successfully over 300,000 times in western countries [1]. A closer look to recent market forecasts shows that the market share of this technology is expected to grow by 14% a year up to 2025.…”

Transcatheter Aortic Valve Replacements: Current Trends and Future Directions

“…41 However, with increasing operator experience and proficiency, overall, the trend of cerebrovascular incidents seems to be decreasing to rates between 1.5% and 6%, with disabling stroke rates of about 1% to 3% at 30 days. 42…”